Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.

At Medipol Bahçelievler Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2022 and is located in Istanbul, Turkey. The hospital has 441 beds and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.
With advanced oncology infrastructure, Special Neolife Medical Center offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2010, the JCI accredited hospital is located in Istanbul, Turkey, and it has adequate bed capacity.
Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.
Medical Park Tokat Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2015 in Tokat, Turkey and has 157 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
VM Medical Park Samsun Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2017 in Samsun, Turkey and has 300 beds to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
At VM Medical Park Ankara, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2014 and is located in Ankara, Turkey. The hospital has 327 beds and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.
At Ekol, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The ISO accredited facility has been functioning since 2000 and is located in Izmir, Turkey. The hospital it has adequate bed capacity and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.
Istanbul Oncology Hospital aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2008 in Istanbul, Turkey and it has adequate bed capacity to care for both domestic and international patients.
Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.
The state-of-the-art Targeted Therapy services offered by Medical Park Gebze Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Kocaeli, Turkey. Founded in 2015, the JCI accredited hospital has 120 beds and provides cancer care facilities for all its local and overseas patients.
Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.
At Guven Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The GHA accredited facility has been functioning since 1975 and is located in Ankara, Turkey. The hospital has 254 beds and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.
At Medstar Antalya Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2009 and is located in Ankara, Turkey. The hospital has 124 beds and serves both international and local patients.
Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing episodes of unconsciousness. After a…

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for Ovarian Cancer Treatment in Turkey.
| Speciality | Oncology |
| Procedure | Targeted Therapy |
| Success Rate | Varies as per stage, grade and type of cancer |
| Recovery Time | Few weeks to several months |
| Treatment Time | A few months to a year |
| Chances of Recurrence | Varies as per stage, grade, type and location of cancer |
The ranking of hospitals according to the procedure is based on a number of elements. The following factors are used to rank hospitals in Turkey that perform Targeted Therapys- Availability of the Procedure, Popularity of the procedure & hospital, Infrastructure, Pricing structure, Experienced Medical Professionals, Technology Employed, Facilities Available for the Patients & Visitors, Success Rate of the Hospital.
MediGence offers you a blend of convenience, quality healthcare, and cost-savings. We wish you to experience a trouble-free and quality healthcare journey, so we make sure that you receive our value-added benefits throughout your journey. Our value-based services include airport transfers, accommodation, 24/7 assistance, Virtual consultation, case manager, and prenegotiated treatment packages with upto a 30% discount. We also provide several additional advantages to help you receive first-rate medical care.
Absolutely! Yes. Before you plan medical travel to Turkey, you can benefit from an efficient & helpful online consultation with the chosen specialist there. You can place your request to our patient advisors for scheduling your online consultation with the specialist. Our expert will cross-check with the specialist about his/her availability and send you a payment link for the confirmation of the appointment.
Many people around the world consider Targeted Therapy in Turkey to be trustworthy due to the high success rate and excellent hospital infrastructure. In addition, there are other parameters that make Turkey the ideal option for Targeted Therapy. They include:
Depending on the patient's health and the complexity of the treatment, different procedures have different recovery times. In addition, post-treatment rehabilitation is extremely important for speeding up recovery and minimizing recovery time. Following surgery, patients must return for follow-up appointments to ensure proper healing and hasten the healing process.